Does ENZALUTAMIDE Cause Hypokalaemia? 101 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 101 reports of Hypokalaemia have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.2% of all adverse event reports for ENZALUTAMIDE.
101
Reports of Hypokalaemia with ENZALUTAMIDE
0.2%
of all ENZALUTAMIDE reports
7
Deaths
54
Hospitalizations
How Dangerous Is Hypokalaemia From ENZALUTAMIDE?
Of the 101 reports, 7 (6.9%) resulted in death, 54 (53.5%) required hospitalization, and 8 (7.9%) were considered life-threatening.
Is Hypokalaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 101 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Hypokalaemia?
FUROSEMIDE (2,503)
HYDROCHLOROTHIAZIDE (1,152)
CARBOPLATIN (1,118)
PREDNISONE (967)
DEXAMETHASONE (876)
CYCLOPHOSPHAMIDE (864)
OMEPRAZOLE (851)
RITUXIMAB (822)
AMLODIPINE (815)
PANTOPRAZOLE (811)
Which ENZALUTAMIDE Alternatives Have Lower Hypokalaemia Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE